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Orthostatic hypotension is defined as a reduction in systolic blood pressure of at least 20 mmHg or a reduction
in diastolic blood pressure of at least 10 mmHg within 3 minutes of standing up. The frequent and rapid
cardiovascular adjustments essential for homeostatic control of blood pressure are not accomplished in patients
with orthostatic hypotension, who experience symptomatic and often extreme high and low blood pressure
variations. In most cases, the underlying cause of orthostatic hypotension is not amenable to correction, and
patients have lifelong symptoms. Current treatment strategies are directed at improving patients’ symptoms by
raising blood pressure. Such interventions, however, do not address the coincident problems of extreme high
blood pressure, nocturnal hypertension, and resultant end-organ damage present in these patients. [Hong Kong
J Nephrol 2005;7(1):51–3]
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Orthostatic hypotension is defined as a reduction
in systolic blood pressure of at least 20 mmHg or
a reduction in diastolic blood pressure of at least 10
mmHg within 3 minutes of standing up [1]. It may be
associated with neurologic and non-neurologic entities,
and 24-hour ambulatory blood pressure monitoring
may demonstrate a reversal of circadian patterns with
nocturnal hypertension [2]. The frequent and rapid
cardiovascular adjustments essential for homeostatic
control of blood pressure are not accomplished in
patients with orthostatic hypotension, who experience
symptomatic and often extreme high and low blood
pressure variations (Figure 1). In most cases, the
underlying cause of orthostatic hypotension is not
amenable to correction, and patients have lifelong
symptoms [3]. Current treatment strategies are directed
at improving patients’ symptoms by raising blood
pressure [4]. Such interventions, however, do not
address the coincident problems of extreme high blood
pressure, nocturnal hypertension, and resultant end-
organ damage present in these patients [5,6].
Symptoms and target-organ damage are caused by
fluctuations in blood pressure control, and a cure for
orthostatic hypotension is currently unavailable for
most patients, thus necessitating strategies that use
combinations of nonpharmacologic and pharmacologic
interventions to attenuate episodes of hypotension and
hypertension. We propose that, initially, attempts be
made to raise the low end of blood pressure to a level
that provides some symptomatic relief to the patient
(Figure 2). In our clinical experience, a standing systolic
blood pressure of 90–120 mmHg provides symptoma-
tic relief to most patients. This level can be achieved
by the gradual introduction of various general and
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nonpharmacologic measures (Table), which aim to
increase blood pressure by augmenting blood volume,
and to promote venous return by translocating blood
from the leg veins and splanchnic vascular bed.
Collectively, these measures can have pronounced
circulatory effects. Drinking water can elicit a potent
pressor response for a short duration (60–90 minutes)
[8], and frequent water ingestion can attenuate
symptoms. For patients who fail to attain the target
standing systolic blood pressure of 90–120 mmHg by
the above interventions, pharmacologic agents can be
used. Midodrine hydrochloride exerts its vasopressor
effects via activation of _-adrenergic receptors in the
arteriolar and venous vasculature, and such effects last
for 3–4 hours [12]. Fludrocortisone acetate possesses
potent mineralocorticoid properties and has a plasma
half-life of 3.5 hours and a biological half-life of 36
hours [13]. Sympathomimetics, erythropoietin, intra-
nasal desmopressin, indomethacin, nadolol, pindolol,
and other agents have been advocated for the ame-
lioration of orthostatic hypotension, although their
clinical efficacy is uncertain. Clinicians should exer-
cise caution to avert the adverse consequences of an
exaggerated hypertensive response, such as renal
impairment or cardiac failure [14].
The abovementioned interventions may be effective
in raising the lower end of the blood pressure spectrum,
but may also lead to worsening of the higher end of the
blood pressure spectrum (Figure 2). The resulting ele-
vated blood pressure is managed with antihyper-
tensive medications as needed to achieve a supine
systolic blood pressure of less than 140 mmHg. Clo-
nidine, an _2-adrenergic receptor agonist, has been
used successfully to control blood pressure lability [4],
but angiotensin-converting enzyme inhibitors may
have the advantage of also inhibiting the progression
of target-organ damage, including nephropathy and
cardiac disease [15]. Diuretics are best avoided, but
`-adrenergic receptor blockers with intrinsic sym-
pathomimetic activity and _1-adrenergic receptor
antagonists may be helpful.
An integral part of this approach to blood pressure
control is active patient and family participation and
easy access to the treating physician, such that the
strategy provides assurance, hope, and empowerment
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Figure 2. Hypothetical outcomes after proposed treatment for
orthostatic hypotension. SBP = systolic blood pressure.
Figure 1. Twenty-four-hour ambulatory blood pressure (24-hour
ABP) monitoring demonstrates characteristic blood pressure (BP)
fluctuations in a patient with orthostatic hypotension. The ABP
monitor concurrently recorded heart rate (circles) and BP (vertical
lines) every 15 minutes during waking hours, and every 30 minutes
while asleep (z). The maximum of each vertical line represents
systolic BP, whereas the minimum represents diastolic BP; hori-
zontal dashed lines represent the upper limits of the reference
ranges for systolic and diastolic BPs. PPH = postprandial hypo-
tension.
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Table. Treatment of orthostatic hypotension
General measures
Exclude treatable medical disorders, medications, and
   volume depletion
Avoid prolonged standing, and sudden posture changes [6]
Avoid alcohol, hot environments, and rigorous exercise
Frequent small meals; two cups of coffee in the morning [7,8]
Sleep with the bed-head elevated (15–20$) [9]
Nonpharmacologic measures to elevate blood pressure
Frequent ingestion of 250–300 mL of water [8]
Salt added to diet (10 g/d) [10]
Compression stockings [11]
Abdominal binder [11]
Pharmacologic measures to increase blood pressure
Midodrine hydrochloride
Fludrocortisone acetate
Sympathomimetics
Erythropoietin (if anemia is present)
Others
Pharmacologic measures to decrease blood pressure
Angiotensin-converting enzyme inhibitors
_2-adrenergic receptor agonists
_1-adrenergic receptor antagonists
`-adrenergic receptor antagonists with intrinsic
   sympathomimetic activity
Step 3. Expected long-term
outcome control
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to the patient. Patients should measure their blood
pressure daily in the morning and at bedtime, in both
the upright and supine positions, and they should chart
their progress, make necessary changes to their
nonpharmacologic prescriptions under predefined
criteria, and regularly follow up with the treating
physician.
Various questions remain regarding the management
of orthostatic hypotension, and ongoing basic and
clinical research will hopefully clarify these issues.
Current treatment strategies, regardless of the specific
medication used, need to be directed at both symptom
relief and prevention of end-organ damage. The in-
corporation of strategies for preventing cardiovascular
mortality also seems prudent.
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